Primary Record
Tozasertib
- In stock
- 7,833 g
- Purity
- 99.2 %
- CAS
- 639089-54-6
Compound Identifiers & Properties
- CAS
- 639089-54-6
- PubChem CID
- 5494449
- SMILES
- CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C
- Canonical SMILES
- Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1
Names & Synonyms
- Tozasertib
- 639089-54-6
- VX-680
- tozasertibum
- MK-0457
- Tozasertib (USAN)
- Tozasertib [USAN]
- VX 680
- Tozasertib (VX-680)
- MK 0457
- VX680
- Tozasertib [USAN:INN]
- C23H28N8OS
- Kinome_3803
- 2f4j
- AC1NUV5F
- TOZASERTIB [INN]
- RefChem:933220
- VX-680 (MK-0457,Tozasertib)
- D02XNW
- Tozasertib (MK-0457)
- CHEMBL572878
- TOZASERTIB [WHO-DD]
- MFCD13185152
- cc-202
- MLS001065920
- SCHEMBL614528
- DTXSID10213609
- GCIKSSRWRFVXBI-UHFFFAOYSA-N
- GTPL5718
- orb1305377
- SCHEMBL2682989
- UNII-234335M86K
- VX-68
- BDBM13534
- CHEBI:91336
- CTK8E8460
- KS-00000XGU
- DTXCID90136100
- QCR-107
- SYN1092
- MK-045
- VE-465
- BCPP000017
- GLXC-90007
- HMS2043N07
- HMS2198F22
- HMS3244O19
- HMS3244O20
- HMS3244P19
- HMS3265C21
- HMS3265C22
- HMS3265D21
- HMS3265D22
- HMS3654I11
- HMS3750O19
- ACT03970
- AOB87770
- BCP01859
- EX-A2179
- Tozasertib(MK-0457,VX-680)
- ZINC3820040
- C23-H28-N8-O-S
- ABP000120
- AN-505
- BDBM50004205
- EBC-11363
- EBC-12792
- MK0457
- NSC745967
- NSC800955
- RS0018
- s1048
- VE 465
- VX-680; Tozasertib; MK-0457
- 234335M86K
- AKOS015902930
- ACN-040198
- CCG-264793
- CID5494449
- CS-0007
- FM28353
- NSC-745967
- NSC-800955
- SB19302
- SDCCGSBI-0654331.P001
- Tozasertib (VX-680, MK-0457)
- VX-680 (MK-0457, Tozasertib)
- VX-680 (Tozasertib, MK-0457)
- VX-680 - MK0457 - Tozasertib
- NCGC00168110-01
- NCGC00168110-02
- NCGC00168110-05
- AK174787
- AM808097
- AS-18632
- HY-10161
- N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide
- SMR000486395
- SY240209
- L-001281814
- VX-680 (MK-0457)
- VX-680, MK-0457, TOZASERTIB
- AB0007989
- DB-361309
- M K 0457
- N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
- A4111
- FT-0652724
- NS00116357
- PA-5494449
- SW212828-2
- W9901
- EC-000.2365
- J2.003.899C
- MK-0457, Tozasertib, VX680, VX-680
- A10981
- A19417
- D08279
- W-5565
- 936915-58-1
- EN300-6743235
- 089V546
- I14-1964
- N-[4-({4-[(3-methyl-1H-pyrazol-5-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide
- Q6605919
- BRD-K59369769-001-02-1
- BRD-K59369769-001-09-6
- BRD-K59369769-001-12-0
- BRD-K59369769-001-14-6
- BRD-K59369769-001-20-3
- BRD-K59369769-001-23-7
- BRD-K87947369-001-01-6
- N-(4-((4-((5-methyl-1H-pyrazol-3-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide
- VX6
- B0084-074159
- Cyclopropanecarboxamide, N-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)-
- Cyclopropanecarboxamide, N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-
- Cyclopropanecarboxamide,N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-
- Cyclopropanecarboxylic Acid {4-[4-(4-Methyl-Piperazin-1-Yl)-6-(5-Methyl-2h-Pyrazol-3-Ylamino)-Pyrimidin-2-Ylsulfanyl]-Phenyl}-Amide
- Cyclopropanecarboxylic acid N-(4-((4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl)sulfanyl)phenyl)amide
- N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide
- N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-cyclopropanecarboxamide
- (N-[4({4-(4-methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5 -yl)amino]pyrimidin-2-yl}thio)phenyl]cyclopropanecarboxamide)
- Cyclopropane carboxylic acid{4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide
- N-(4-((4-((3-methyl-1H-pyrazol-5-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide
- N-(4-((4-(4-Methylpiperazin-1-yl)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide
- N-[4-({4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide
- cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2h-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide
- cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2ylsulphanyl]-phenyl}-amide
- cyclopropane carboxylic acid N-(4-(4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-ylsulfanyl)phenyl)amide
- cyclopropane carboxylic acid(4-(4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-ylsulfanyl)phenyl)amide
- Cyclopropanecarboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-1H-pyrazol-3-ylamino)-pyrimidin-2-ylsulfanyl]-phenyl}-amide
- N-(4-((4-((3-methyl-1H-pyrazol-5-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide
- N-(4-(4-(5-methyl-1H-pyrazol-3-ylamino)-6-(1-methylpiperidin-4-ylamino)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide
- N-?[4-?[[4-?(4-?methyl-?1-?piperazinyl)-?6-?[(5-?methyl-?1H-?pyrazol-?3-?yl)amino]-?2-?pyrimidinyl]thio]phenyl]-?cyclopropanecarboxamide
- N-[4-({4-(4-methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5-yl)amino]pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide
- N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide
- N-[4-[[4-(3-Methyl-1H-pyrazole-5-ylamino)-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide
- N-[4-[[4-(4-Methylpiperazine-1-yl)-6-[(3-methyl-1H-pyrazole-5-yl)amino]pyrimidine-2-yl]thio]phenyl]cyclopropane-1-carboxamide
- N-[4-[[4-(4-methylpiperazino)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]thio]phenyl]cyclopropanecarboxamide
- N-[4-[[4-[(3-Methyl-5-pyrazolyl)amino]-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide